BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17113149)

  • 41. Cryptic deletion of EGR1 in association with a novel balanced t(5;22)(q31;q11.2) in a patient with myelodysplastic syndrome.
    Hoffman MW; Janney S; Batanian JR
    Cancer Genet Cytogenet; 2009 Jun; 191(2):106-8. PubMed ID: 19446747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular profiling in the age of cancer genomics.
    Lin J; Li M
    Expert Rev Mol Diagn; 2008 May; 8(3):263-76. PubMed ID: 18598106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How I investigate dysgranulopoiesis.
    Shekhar R; Srinivasan VK; Pai S
    Int J Lab Hematol; 2021 Aug; 43(4):538-546. PubMed ID: 34031992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low expression of tissue inhibitor of metalloproteinase-2 may be associated with high-risk myelodysplastic syndrome.
    Melo Rde C; Arouca MM; Bigarella CL; Baratti MO; Campos Pde M; Traina F; Saad ST
    Leuk Lymphoma; 2013 May; 54(5):1091-3. PubMed ID: 22957840
    [No Abstract]   [Full Text] [Related]  

  • 45. Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome.
    Stubbins RJ; Cherniawsky H; Chen LYC; Nevill TJ
    CMAJ; 2022 Apr; 194(14):E524-E527. PubMed ID: 35410861
    [No Abstract]   [Full Text] [Related]  

  • 46. Sonic hedgehog produced by bone marrow-derived mesenchymal stromal cells supports cell survival in myelodysplastic syndrome.
    Zou J; Hong Y; Tong Y; Wei J; Qin Y; Shao S; Wang C; Zhou K
    Stem Cells Int; 2015; 2015():957502. PubMed ID: 25861282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in hematopoietic microenvironment in patients with aplastic anemia.
    Shipounova IN; Petrova TV; Svinareva DA; Momotuk KS; Mikhailova EA; Drize NI
    Clin Transl Sci; 2009 Feb; 2(1):67-74. PubMed ID: 20443870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study.
    Garderet L; Kobari L; Mazurier C; De Witte C; Giarratana MC; Pérot C; Gorin NC; Lapillonne H; Douay L
    Haematologica; 2010 Mar; 95(3):398-405. PubMed ID: 19815832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.
    Kerbauy DB; Deeg HJ
    Exp Hematol; 2007 Nov; 35(11):1739-46. PubMed ID: 17976524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
    Bernasconi P
    Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene expression profiling in the myelodysplastic syndromes.
    Pellagatti A; Fidler C; Wainscoat JS; Boultwood J
    Hematology; 2005 Aug; 10(4):281-7. PubMed ID: 16085540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal stromal cells in myelodysplastic syndromes: genomics presents further evidence.
    Mayani H
    Leuk Res; 2007 May; 31(5):577-8. PubMed ID: 17113149
    [No Abstract]   [Full Text] [Related]  

  • 53. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
    Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
    Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.
    Borojevic R; Roela RA; Rodarte RS; Thiago LS; Pasini FS; Conti FM; Rossi MI; Reis LF; Lopes LF; Brentani MM
    Leuk Res; 2004 Aug; 28(8):831-44. PubMed ID: 15203281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression.
    Michalopoulou S; Micheva I; Karakantza M; Kouraklis-Symeonidis A; Mouzaki A; Zoumbos NC
    Haematologica; 2006 Dec; 91(12):1714-6. PubMed ID: 17145614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Functional characteristics of hematopoietic and stromal cells in various forms of myelodysplastic syndrome].
    Gerasimova LP; Manakova TE; Tsvetaeva NV; Lukina EA; Kozlovskaia AS
    Biull Eksp Biol Med; 1999 Jan; 127(1):14-8. PubMed ID: 10189996
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.